ICDD
Home About Agenda Speakers Register Location Committee

2015 Speakers TBA

 


2014 Speakers

Sandy Allerheiligen, Ph.D.
Vice President Quantitative Pharmacology and Pharmacometrics
Merck Research Laboratories

Ethan Basch, M.D.
Director, Cancer Outcomes Research Program
Associate Professor, Medicine and Public Health
UNC Lineberger Comprehensive Cancer Center 
University of North Carolina-Chapel Hill

Lisa Bell, Ph.D.
Vice President, Regulatory Affairs and Pharmacovigilance
BioMarin

Donald A. Berry, Ph.D.
Professor, Department of Biostatistics
The University of Texas MD Anderson Cancer Center

Lynn Crismon, Pharm.D., FCCP, BCCP
Dean, James T. Doluisio Regents Chair in Pharmacy Fellowship, Behrens Inc.
Centennial Professor of Health Outcomes & Pharmacy Practice
The University of Texas at Austin College of Pharmacy

Mwango Kashoki, M.D.
Medical Officer, Office of New Drugs
CDER, FDA

Steven Lynn, M.S.
Director, Office of Manufacturing and Product Quality (OMPQ)
OC, CDER, FDA

Tracy Mayne, Ph.D.
Vice President, Global Health Economics and Outcomes Research
Covance

Sarah Pope Miksinski
Division Director (Acting)
FDA, CDER, OPS, ONDQA, DNDQA 2

Moheb M. Nasr, Ph.D.
Vice President, CMC Regulatory Strategy
GlaxoSmithKline, R&D

Roger Nosal
Vice President, Global CMC
Pfizer, Inc.

Debra J Rasmussen, MBA, RAC
Senior Director Global Regulatory Affairs
Janssen Pharmaceuticals

Paula Rinaldi
North America Head, Drug Regulatory Affairs
Novartis Pharmaceuticals

Carlo Russo, M.D.
Senior Vice President, Alternative Development Program
Head, Alternative Discovery & Development
Interim Head, Rare Disease Development
GlaxoSmithKline

Ray Sacchetti
Senior Vice President, US Virology & Transplant
Bristol-Myers Squibb

Salomon Stavchansky, Ph.D.
ICD2 Conference Scientific Chair
Alcon Centennial Professor of Pharmaceutics
The University of Texas at Austin College of Pharmacy

J. Russell Teagarden, RPh., M.A.
Senior Vice President, Medical & Scientific Affairs
National Organization for Rare Disorders (NORD)

Janet Woodcock, M.D.
Director • Center for Drug Evaluation & Research
CDER, FDA

Isaam Zineh, PharmD, MPH, FCP, FCCP
Director, Office of Clinical Pharmacology
Office of Translational Sciences
CDER, FDA

 



Last Reviewed: June 26, 2014

ACPE The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Comments to: UTPharmacyCE@austin.utexas.edu
Download free PDF Reader | Download free MS Reader
Privacy Policy | Accessibility Policy
©2012 College of Pharmacy, The University of Texas at Austin
Make a Gift